Surgi-Care, Inc.
$31.9K 25 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Electronic Waveform Lab, Inc.
Electronic Waveform Lab, Inc. reported $31,992.54 across General Payments, Research, and Ownership to 1,902 physicians and teaching hospitals across 1,902 transactions.
- $32.0K Below-median payer
- All-tracks total
- 1,902 Top quartile volume
- Transactions
- 1,902 Top quartile reach
- Recipients
- −$14.3K
- General Payments vs PY2023
Electronic Waveform Lab, Inc. reported $31,992.54 across all CMS Open Payments tracks (General + Research + Ownership) to 1,902 physicians and teaching hospitals in Program Year 2024 - ranking #1455 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $31,992.54, averaging $16.82 per recipient.
Electronic Waveform Lab, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
24/100
Physician reach
F
24/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer electronic-waveform-lab-inc Electronic Waveform Lab, Inc.
$32.0K · #1455/1,925 · 0.0% industry · PY2024
- TOT $32.0K
- RANK #1455
- SHARE 0.0%
- TXN 1,902
- RCP 1,902
- CAT 1
- GEN $32.0K
- ΔGEN −$14.3K
- TOP1 2.0%
- PY 2024
Volume peers
Nearest volume peer: Surgi-Care, Inc. ($31.9K)
Electronic Waveform Lab, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Electronic Waveform Lab, Inc.'s CMS-reported General Payments decreased by $14.3K (−31.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ELECTRONIC WAVEFORM LAB, INC.PY2023: ELECTRONIC WAVEFORM LAB, INC.PY2024: Electronic Waveform Lab, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $46,334.42
- PY2024
- $31,992.54
What the Data Shows for Electronic Waveform Lab, Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Electronic Waveform Lab, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $32.0K across 1,902 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Electronic Waveform Lab, Inc.'s 1-category general-payment breakdown at $32.0K, 100.0% of the reported total.
How Electronic Waveform Lab, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $32.0K | 1,902 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,549.44 (8.0%) of $31,992.54 in this company's General Payments records across 592 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Electronic Waveform Lab, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Natalia Balytsky
$649.85 across 18 reported transactions
- 2
Darrel Saldanha
$554.81 across 5 reported transactions
- 3
Robert Greiner
$470.39 across 27 reported transactions
- 4
Christopher Jones
$437.33 across 3 reported transactions
- 5
William Hayduk
$437.06 across 19 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Electronic Waveform Lab, Inc. ranks #1455 of 1,925 by total payments (bottom 24% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,763 of 1,838 by HHI (bottom 4% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Eisai Inc. : $7.1M total payments, HHI 55
- Amgen Inc. : $44.9M total payments, HHI 55
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) : $10.8M total payments, HHI 52
- Mylan Specialty L.P. : $1.4M total payments, HHI 51
- Virtus Pharmaceuticals LLC : $19.8K total payments, HHI 50
- Madrigal Pharmaceuticals : $4.5M total payments, HHI 49
- Electronic Waveform Lab, Inc. (this company) : $32.0K total payments, HHI 47
- Avvisto Therapeutics, LLC : $8.9K total payments, HHI 47
- Neurocrine Biosciences, Inc. : $14.2M total payments, HHI 47
- W. L. Gore & Associates, Inc. : $5.4M total payments, HHI 47
- Aucta Pharmaceuticals, Inc. : $25.2K total payments, HHI 46
- Axsome Therapeutics, Inc. : $12.2M total payments, HHI 45
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Electronic Waveform Lab, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Electronic Waveform Lab, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Electronic Waveform Lab, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Smaio SA
$32.3K 70 recipients
Compare payment profiles
Optos plc
$31.7K 31 recipients
Compare payment profiles
Ion Beam Applications S.A.
$32.3K 17 recipients
Compare payment profiles
Dentsply Sirona KK
$32.4K 13 recipients
Compare payment profiles
Lupin Inc.
$31.5K 12 recipients
Compare payment profiles
Put this to use
Electronic Waveform Lab, Inc. ranks #1455 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Electronic Waveform Lab, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.